Tehran (ISNA) – The first phase of a clinical trial for another Iranian COVID-19 vaccine named “Fakhra” was launched on Tuesday with Defense Minister Brigadier General Amir Hatami and Health Minister Saeed Namaki in attendance.
The new COVID-19 vaccine named after the martyred nuclear scientist Mohsen Fakhrizadeh, who was assassinated in a suspected Israeli-linked terror attack late last year.
Fakhrizadeh’s son received the first dose of the new vaccine.
“The Fakhra vaccine’s tests on animal models have proven extremely effective and the human trials begin today. The design and construction of a factory for the vaccine’s mass production has started and it seems that it will enter the production phase in summer,” the spokesman for Food and Drug Administration of Iran told ISNA.